Arthritis drug sparks notable hair regrowth in alopecia trials
TL;DR Summary
An oral arthritis medication called upadacitinib demonstrated substantial hair regrowth in two international trials for severe alopecia areata, with about half of participants achieving at least 80% scalp coverage after 24 weeks; some reached complete restoration. While promising, results vary by patient and longer-term effects and safety still need assessment.
- Drug used for arthritis shows promise against severe hair loss Interesting Engineering
- Rheumatoid arthritis drug also may help people with hair loss caused by severe alopecia PhillyVoice
- Arthritis drug restores 100% hair on 1 in 5 alopecia patients in global trial South China Morning Post
- Efficacy and Safety of JAK Inhibitors for Alopecia Areata Docwire News
- Q&A: Upadacitinib's Safety Profile and Role in Severe Alopecia Areata Care HCPLive
Reading Insights
Total Reads
1
Unique Readers
9
Time Saved
6 min
vs 7 min read
Condensed
96%
1,308 → 50 words
Want the full story? Read the original article
Read on Interesting Engineering